Moving Forward in Multiple Myeloma

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 45 Minutes

Overview

This program offers an in-depth exploration of multiple myeloma treatment and management. Participants will delve into the latest therapeutic advancements, including new indications for daratumumab-VRd and isatuximab-KRd, and strategies for managing relapsed disease. Through case-based scenarios, attendees will gain practical insights into optimizing supportive care and integrating novel therapies such as CAR T-cell treatments and bispecific antibodies into clinical practice.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Review new indications for daratumumab-VRd and isatuximab-KRd in multiple myeloma that reflect advances in treatment protocols for newly diagnosed individuals
  2. Discuss recent updates in the treatment protocols for the relapsing patient
  3. Outline optimal supportive care practices for managing patients with multiple myeloma
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
09/05/2025
Course expires: 
09/05/2026
Cost:
$0.00
Rating: 
0

Faculty

Tiffany Richards, PhD, ANP, AOCNP

APP Manager Lymphoma/Myeloma
MD Anderson Cancer Center
Houston, TX

Tiffany Richards, PhD, ANP, AOCNP received her Masters Degree from the University of Wisconsin-Madison and her PhD from Texas Woman’s University.  Ms. Richards is presently employed as an Adult Nurse Practitioner at the MD Anderson Cancer Center in the Department of Lymphoma/Myeloma.  

In addition to the above, Ms. Richards is involved with the following committees and offices:  Multiple Myeloma Support Group: Co-facilitator 2008-present; International Myeloma Foundation Nurse Leadership Board 2007-present.  She has published and presented on multiple myeloma and other plasma cell dyscrasias.  

Ms. Richards has been honored with the following awards:  MD Anderson’s 2008 Excellence in Advanced Practice Nursing; Texas Nurses Association-Houston Chapter Top 20 Nurses for 2008 Award; 2008 South Central Nurse Excellence Award Finalist; Oncology Nursing Society Excellence in Public/Patient Education; and the MD Anderson 2013 Division of Medicine Exemplary Employee Award.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Tiffany Richards PhD, ANP, AOCNP declares the following financial relationships:

Advisory Boards: Sanofi, Bristol-Myers Squibb, Takeda

Consulting Fee: Pfizer, Johnson & Johnson
 

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above